EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sphingosine‐1‐Phosphate Promotes FOS Activation in Osteosarcoma Under Tumor Acidosis

Nicolò Bozzini iD, Margherita Cortini, Alberto Righi, Agamemnon E Grigoriadis iD, Michael Dack, Elizabeta Ilieva, Federica Torricelli, Veronica Manicardi iD, Nicola Baldini iD, Sofia Avnet iD

Acta Physiologica · 2026

DOI: 10.1111/apha.70214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Nicolò Bozzini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Acidosis, Bone Neoplasms, Epigenesis, Genetic, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, European Union-Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The tumor microenvironment in solid tumors is characterized by extracellular acidosis, which promotes cancer aggressiveness. In osteosarcoma, the most common primary bone cancer, a highly acidic tumor microenvironment is associated with metastasis and poor prognosis, partly due to metabolic rewiring, including changes in lipid pathways such as those involving sphingosine‐1‐phosphate, a bioactive sphingolipid. Sphingosine‐1‐phosphate has been previously implicated in histone deacetylase inhibition and gene activation. Here, we investigated whether acidosis induces nuclear sphingosine‐1‐phosphate accumulation via sphingosine kinase 2, leading to epigenetic activation of oncogenes like FOS in osteosarcoma.

Methods

Osteosarcoma spheroids were cultured under neutral or acidic conditions. Histone H3 acetylation was assessed by capillary Western blotting. FOS expression and FOS nuclear localization were analyzed. Sphingosine‐1‐phosphate's role was addressed through sphingosine kinase 2 silencing and inhibition (ABC294640). Functional effects were measured using colony formation assays. Patient‐derived OS tissues ( n = 7) were analyzed for correlations between acidity markers (LAMP2, V‐ATPase), sphingosine kinase 2, and FOS expression.

Results

Acidosis increased both sphingosine kinase 2 mRNA expression after 24 h and histone H3 acetylation, which followed progressive FOS upregulation and nuclear FOS accumulation. Sphingosine kinase 2 inhibition or silencing reduced these effects and impaired clonogenicity. In patient tissues, sphingosine kinase 2 levels correlated with acidosis markers and FOS expression.

Conclusions

We identified a novel mechanism where acidosis stimulates both nuclear sphingosine kinase 2 to synthesize sphingosine‐1‐phosphate and histone H3 acetylation, ultimately leading to FOS transcription. Targeting this axis decreased clonogenesis, underscoring its therapeutic potential in osteosarcoma and potentially other acid‐adapted cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcidosisBone NeoplasmsEpigenesis, GeneticGene Expression Regulation, NeoplasticLysophospholipidsOsteosarcomaProto-Oncogene Proteins c-fosSphingosineHumansAdamantaneCell Line, TumorPyridinesSpheroids, CellularSphingosine KinaseTumor MicroenvironmentDisease Progression

Stichwörter der Autor:innen

FOSacidosisepigeneticsosteosarcomasphingosine kinase 2sphingosine‐1‐phosphatetumor microenvironment

Substanzen

3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amideAdamantaneLysophospholipidsProto-Oncogene Proteins c-fosPyridinesSphingosinesphingosine 1-phosphateSphingosine Kinasesphingosine kinase 2, human

Autor:innen und Institutionen

  • Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Centre for Craniofacial and Regenerative Biology, King's College London, Guy's Hospital, London, UK.
  • Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Biomedical Science, Technologies, and Nanobiotechnology Lab, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

ORCID-Profile: Nicolò Bozzini, Agamemnon E Grigoriadis, Veronica Manicardi, Nicola Baldini, Sofia Avnet

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS
  • European Union-Next Generation EU

Zitieren

APA

Bozzini, N., Cortini, M., Righi, A., Grigoriadis, A. E., Dack, M., Ilieva, E., Torricelli, F., Manicardi, V., Baldini, N., & Avnet, S. (2026). Sphingosine‐1‐Phosphate Promotes FOS Activation in Osteosarcoma Under Tumor Acidosis. Acta Physiologica. https://doi.org/10.1111/apha.70214

Vancouver

Bozzini N, Cortini M, Righi A, Grigoriadis AE, Dack M, Ilieva E, et al. Sphingosine‐1‐Phosphate Promotes FOS Activation in Osteosarcoma Under Tumor Acidosis. Acta Physiologica. 2026. doi:10.1111/apha.70214

BibTeX
@article{Bozzini2026,
  author = {Bozzini, Nicolò and Cortini, Margherita and Righi, Alberto and Grigoriadis, Agamemnon E and Dack, Michael and Ilieva, Elizabeta and Torricelli, Federica and Manicardi, Veronica and Baldini, Nicola and Avnet, Sofia},
  title = {Sphingosine‐1‐Phosphate Promotes FOS Activation in Osteosarcoma Under Tumor Acidosis},
  journal = {Acta Physiologica},
  year = {2026},
  doi = {10.1111/apha.70214}
}
Kostenlos starten →